Hepatitis :: Acute Viral Hepatitis Cases Down in US

The three most common forms of acute viral hepatitis in the United States ? hepatitis A, B and C ? declined dramatically between 1995 and 2005, with hepatitis A and B at the lowest levels ever recorded since the government began collecting surveillance data more than 40 years ago, according to the Centers for Disease Control and Prevention (CDC). Hepatitis B and C are diseases that can lead to liver cancer and death.

HIV :: ICC Cricket World Cup West Indies 2007 to highlight HIV

The International Cricket Council (ICC) will team up with UNAIDS, UNICEF and the Caribbean Broadcast Media Partnership on HIV/AIDS at the ICC Cricket World Cup 2007 to highlight the situation of children and young people living with and affected by HIV.

HIV :: Proteochemometrics achieves better retardants for HIV Aids

A new method for analysis of retroviral proteins gives new opportunities to the development of novel retardants for HIV/Aids. The study, which was published in the March issue of PLoS Computational Biology, shows how to in a very exact way analyze the interaction of drug targets with small molecules.

Bird Flu :: Egyptian boy tests positive for bird flu

A four-year-old boy from the Nile Delta town of Daqahliya tested positive for the H5N1 virus on 11 March. Sayyid al-Abbasi, a spokesman for the Ministry of Health, said the boy had contracted the virus from domestic birds raised by his family. He added that his condition was stable.

Influenza :: Roche files supplemental new drug application for Tamiflu

Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg. Tamiflu, which is indicated for the prevention and treatment of influenza types A and B in patients one year and older, is currently available in a 75 mg capsule for adults as well as liquid suspension formulation for children.

HIV :: Nevada scientist authors influential AIDS HIV paper

The decade-long research that University of Nevada, Reno College of Science Chemistry Professor Thomas Bell has invested in the development of an extremely effective HIV/AIDS-fighting compound received an important boost recently when one of Bell’s articles made the list of the 100 most influential publications in the HIV/AIDS research field for 2006.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack